BioSpace News Archive

BioForest

Frazier Healthcare Partners Closes Oversubscribed $780 Million Growth Buyout Fund

Frazier Healthcare Partners, a leading healthcare-focused investment firm founded in 1991, today announced the closing of Frazier Healthcare Growth Buyout Fund IX, L.P. with $780 million in committed capital.

April 10, 2018

·

2 min read

Job Trends

GB Sciences Pursues FDA-Registered, First-in-Human Trial of Cannabis-based Therapy for Parkinson’s Disease

GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies for the treatment of early to moderate Parkinson’s disease (“PD”).

April 10, 2018

·

3 min read

Pharm Country

Applied DNA to Debut Security Print Platform Solution Featuring Videojet 1860M CIJ Printer at INTERPHEX 2018

Applied DNA Sciences, Inc.will debut its security print platform solution featuring the Videojet 1860M continuous inkjet (CIJ) printer at INTERPHEX 2018 in Booth 3957 at the Jacob K. Javits Convention Center in New York City on April 17-19.

April 10, 2018

·

5 min read

Business

U.S. News and Binary Fountain Team Up to Add Patient Experience Ratings to Online Doctor Profiles

U.S. News & World Report announced a new collaboration with Binary Fountain, the leading provider of patient feedback management solutions with one of the largest data repositories of online patient reviews and surveys in the healthcare industry.

April 10, 2018

·

3 min read

Drug Development

Abide Therapeutics Presents Positive Data from a Phase 1b Study of ABX-1431 in Tourette Syndrome at the American Academy of Neurology 70th Annual Meeting

ABX-1431 Study Data Featured in AAN Emerging Science Session Data Blitz Single Oral Doses of ABX-1431 Demonstrate Statistically Significant Activity in Tourette Syndrome

April 10, 2018

·

3 min read

Drug Development

GT Biopharma, Inc. Announces it has Completed Enrollment in Proof-of-concept Clinical Trial for its Novel Treatment for Motion Sickness

The primary objective of the study will be to demonstrate the anti-motion sickness efficacy of transdermal GTP-011.

April 10, 2018

·

4 min read

Business

Torque Expands Leadership Team with Appointment of Thomas Andresen, PhD, as Chief Scientific Officer

Torque, an immuno-oncology company developing Deep Primed™ cellular therapies with pharmacologic control to direct immune power deep within the tumor microenvironment, announced today the appointment of Thomas Andresen, PhD, as Chief Scientific Officer.

April 10, 2018

·

3 min read

Revolutionary New Heart Valve Repair -- Performed for The First Time In Patients -- Demonstrates Feasibility of New Suture Based Technique

HeartStitch®, Inc. And National Research Cardiac Surgery Center in Astana Announce Successful Clinical Test of Novel Tricuspid Valve Repair With Minimally Invasive HeartStitch® Suture Technique On Two Patients.

April 10, 2018

·

8 min read

Lone Star Bio

Using a Home Test Kit and Smartphone to Test for Kidney Disease

New Clinical Trial Screen Hypertensive Population

April 10, 2018

·

5 min read

Leviticus Cardio Confirms the Successful Completion of a Long-term Chronic Animal Study

Leviticus Cardio, the inventor of wireless power transfer for Left Ventricular Assisted Devices, or “LVADs”, for patients with severe cardiac issues, has announced another round of successful animal trials, well beyond periods required to demonstrate suitability for chronic conditions.

April 10, 2018

·

2 min read